STAT

Sanders and Cummings, citing ‘polite f-u letters,’ urge feds to step up probes of generic makers

Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.), citing 'polite f-u letters' from drug makers, urge feds to step up probes.
Source: Alex Wong/Getty Images

As dozens of states pursue numerous generic drug makers for price-fixing, a pair of prominent lawmakers have complained to the Justice Department about a “lack of enforcement” and asked the agency to accelerate its own investigation into the companies.

In a sent to the feds on Wednesday, Sen. Bernie Sanders (I-Vt.)

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks